Literature DB >> 22968341

The usefulness of glycated hemoglobin A1c (HbA1c) for identifying dysglycemic states in individuals without previously diagnosed diabetes.

E Adamska1, M Waszczeniuk, J Gościk, A Golonko, J Wilk, J Pliszka, K Maliszewska, D Lipińska, R Milewski, A Wasilewska, A Citko, A Nikołajuk, L Ostrowska, A Krętowski, M Górska.   

Abstract

PURPOSE: We investigated HbA1c's validity as a screening parameter for excluding dysglycemic states in the studied population. MATERIAL/
METHODS: Sensitivity and specificity of HbA1c in some cut-off points were compared with diagnoses based on the oral glucose tolerance test (OGTT) in individuals diagnosed between 2009-2010. Receiver operating characteristic (ROC) analysis for HbA1c was conducted. HbA1c and OGGT measures were done in 441 people (253 women, 187 men, average age 40.1 years (18-79 years)). Based on the OGGT test 37 individuals were diagnosed as diabetic, 28 as impaired glucose tolerant (IGT) and 63 as having impaired fasting glycemia (IFG).
RESULTS: A cut-off value of 6.5% HbA1c classifies diabetic subjects with a sensitivity of 45.9% and specificity of 97.5%. In the investigated population the best cut-off point (the highest sum of the sensitivity and specificity) was 5.9% HbA1c (sensitivity 86.6%, specificity 73%). HbA1c values excluding the risk of dysglycemic states have shown false negative rate in 31.9% when HbA1c was 5.5% and 10.6% when HbA1c was 5.0%.
CONCLUSIONS: Our results indicate that in the investigated population the evaluation of the prevalence of type 2 diabetes using HbA1c values proposed by the American Diabetes Association (ADA) has unsatisfactory sensitivity and detects less than a half of cases of diabetes based on the OGTT diagnoses. HbA1c 5.7% does not have sufficient specificity to identify individuals not being at risk of any disorder of glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968341     DOI: 10.2478/v10039-012-0030-x

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  5 in total

1.  Impact of a Comprehensive Guideline Dissemination Strategy on Diabetes Diagnostic Test Rates: an Interrupted Time Series.

Authors:  Jennica Nichols; Baiju R Shah; Priscila Pequeno; Carolyn Gall Casey; Catherine H Yu
Journal:  J Gen Intern Med       Date:  2020-03-10       Impact factor: 5.128

2.  Protocol for the CHORD project (community health outreach to reduce diabetes): a cluster-randomized community health worker trial to prevent diabetes.

Authors:  Nadia Islam; Thomas Gepts; Isaac Lief; Radhika Gore; Natalie Levy; Michael Tanner; Yixin Fang; Scott E Sherman; Mark D Schwartz
Journal:  BMC Public Health       Date:  2018-04-19       Impact factor: 3.295

3.  Using hemoglobin A1C as a predicting model for time interval from pre-diabetes progressing to diabetes.

Authors:  Chen-Ling Huang; Usman Iqbal; Phung-Anh Nguyen; Zih-Fang Chen; Daniel L Clinciu; Yi-Hsin Elsa Hsu; Chung-Huei Hsu; Wen-Shan Jian
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

4.  The relationship between the leptin/ghrelin ratio and meals with various macronutrient contents in men with different nutritional status: a randomized crossover study.

Authors:  Edyta Adamska-Patruno; Lucyna Ostrowska; Joanna Goscik; Barbara Pietraszewska; Adam Kretowski; Maria Gorska
Journal:  Nutr J       Date:  2018-12-28       Impact factor: 3.271

5.  Effect of glycemic gap upon mortality in critically ill patients with diabetes.

Authors:  Ran Lou; Li Jiang; Bo Zhu
Journal:  J Diabetes Investig       Date:  2021-08-03       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.